Vancomycin-resistant enterococci: why are they here, and where do they come from?

[1]  R. Weinstein,et al.  Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  N. Woodford,et al.  Frequency of esp in Enterococcus faecium isolates , 2001, The Lancet.

[3]  R. Gaynes,et al.  The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units , 2001, Annals of Internal Medicine.

[4]  M. Kaufmann,et al.  Characterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. , 2001, Journal of medical microbiology.

[5]  A. Belkum,et al.  Enterobacter species in a pediatric hospital: horizontal transfer or selection in individual patients? , 2001, The Journal of infectious diseases.

[6]  Arto S. Baghdayan,et al.  Role of Enterococcus faecalisSurface Protein Esp in the Pathogenesis of Ascending Urinary Tract Infection , 2001, Infection and Immunity.

[7]  Frank Møller Aarestrup,et al.  Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark , 2001, Antimicrobial Agents and Chemotherapy.

[8]  G. Gherardi,et al.  Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium , 2001, The Lancet.

[9]  atthew,et al.  Control of vancomycin-resistant enterococcus in health care facilities in a region. , 2001, The New England journal of medicine.

[10]  M. Graham,et al.  Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid , 2001, The Lancet.

[11]  S. Amyes,et al.  Diversity of Tn1546 Elements in Clinical Isolates of Glycopeptide-Resistant Enterococci from Scottish Hospitals , 2001, Antimicrobial Agents and Chemotherapy.

[12]  Janetta Top,et al.  Variant esp gene as a marker of a distinct genetic lineage of vancomycinresistant Enterococcus faecium spreading in hospitals , 2001, The Lancet.

[13]  Paul D. R. Johnson,et al.  Enterococcal vanB resistance locus in anaerobic bacteria in human faeces , 2001, The Lancet.

[14]  A. Voss,et al.  Molecular Analysis of Tn1546-Like Elements in Vancomycin-Resistant Enterococci Isolated from Patients in Europe Shows Geographic Transposon Type Clustering , 2001, Antimicrobial Agents and Chemotherapy.

[15]  L. Rice.  Emergence of vancomycin-resistant enterococci. , 2001, Emerging infectious diseases.

[16]  A. Sohn,et al.  Reality Check: Should We Try to Detect and Isolate Vancomycin-Resistant Enterococci Patients? , 2001, Infection Control & Hospital Epidemiology.

[17]  M. Bonten,et al.  [Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital]. , 2000, Nederlands tijdschrift voor geneeskunde.

[18]  M. Bonten,et al.  [Vancomycin-resistant Enterococcus faecium outbreak in a nephrology ward]. , 2000, Nederlands tijdschrift voor geneeskunde.

[19]  L. Rice,et al.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.

[20]  B. de Jonghe,et al.  “Colonization Pressure” and Risk of Acquisition of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit , 2000, Infection Control & Hospital Epidemiology.

[21]  J. Turnidge,et al.  Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis , 2000, Antimicrobial Agents and Chemotherapy.

[22]  J. Meis,et al.  Prevalence of Vancomycin-Resistant Enterococci in Europe , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  M. Hayden.  Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  H. Endtz,et al.  Host specificity of vancomycin-resistant Enterococcus faecium. , 2000, The Journal of infectious diseases.

[25]  W. Hryniewicz,et al.  Outbreak of Vancomycin-Resistant Enterococci in a Hospital in Gdańsk, Poland, due to Horizontal Transfer of Different Tn1546-Like Transposon Variants and Clonal Spread of Several Strains , 2000, Journal of Clinical Microbiology.

[26]  A. Sundsfjord,et al.  Continuing high prevalence of VanA‐type vancomycin‐resistant enterococci on Norwegian poultry farms three years after avoparcin was banned , 2000, Journal of applied microbiology.

[27]  E. Stobberingh,et al.  The effect of banning avoparcin on VRE carriage in The Netherlands. , 2000, The Journal of antimicrobial chemotherapy.

[28]  D. Livermore,et al.  Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. , 2000, The Journal of antimicrobial chemotherapy.

[29]  L. Rice,et al.  Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. , 2000, The Journal of infectious diseases.

[30]  R. Patel.  Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. , 2000, FEMS microbiology letters.

[31]  B. Murray,et al.  Vancomycin-resistant enterococcal infections. , 2000, The New England journal of medicine.

[32]  M. Kaufmann,et al.  Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children , 2000, Epidemiology and Infection.

[33]  E. Tarkka,et al.  vanA and vanB Incorporate into an Endemic Ampicillin-Resistant Vancomycin-SensitiveEnterococcus faecium Strain: Effect on Interpretation of Clonality , 1999, Journal of Clinical Microbiology.

[34]  Nnis System,et al.  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.

[35]  Y. Carmeli,et al.  The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. , 1999, Archives of internal medicine.

[36]  J. Top,et al.  Enterococci with Glycopeptide Resistance in Turkeys, Turkey Farmers, Turkey Slaughterers, and (Sub)Urban Residents in the South of The Netherlands: Evidence for Transmission of Vancomycin Resistance from Animals to Humans? , 1999, Antimicrobial Agents and Chemotherapy.

[37]  G. Wormser,et al.  Infection-Control Measures Reduce Transmission of Vancomycin-Resistant Enterococci in an Endemic Setting , 1999, Annals of Internal Medicine.

[38]  S. Eykyn,et al.  A 25-year study of nosocomial bacteremia in an adult intensive care unit. , 1999, Critical care medicine.

[39]  L. Rice,et al.  Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. , 1999, The Journal of infectious diseases.

[40]  H. Goossens,et al.  Comparison of Glycopeptide-ResistantEnterococcus faecium Isolates and Glycopeptide Resistance Genes of Human and Animal Origins , 1999, Antimicrobial Agents and Chemotherapy.

[41]  R. Anderson,et al.  Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Nicole,et al.  Molecular Diversity and Evolutionary Relationships of Tn1546-Like Elements in Enterococci from Humans and Animals , 1999, Antimicrobial Agents and Chemotherapy.

[43]  Arto S. Baghdayan,et al.  Infection-Derived Enterococcus faecalisStrains Are Enriched in esp, a Gene Encoding a Novel Surface Protein , 1999, Infection and Immunity.

[44]  L. Jensen.  Internal size variations in Tn1546-like elements due to the presence of IS1216V. , 1998, FEMS microbiology letters.

[45]  N. Woodford,et al.  Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. , 1998, The Journal of antimicrobial chemotherapy.

[46]  H. Wegener.  Historical Yearly Usage of Glycopeptides for Animals and Humans: The American-European Paradox Revisited , 1998, Antimicrobial Agents and Chemotherapy.

[47]  S. Amyes,et al.  Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. , 1998, The Journal of hospital infection.

[48]  L. Jensen.  Differences in the Occurrence of Two Base Pair Variants of Tn1546 from Vancomycin-Resistant Enterococci from Humans, Pigs, and Poultry , 1998, Antimicrobial Agents and Chemotherapy.

[49]  Friedhelm Schuster1,et al.  Vancomycin-resistant-enterococci - Colonization of 24 patients on a pediatric oncology unit , 1998, Klinische Padiatrie.

[50]  H. Endtz,et al.  Molecular Characterization of Vancomycin-Resistant Enterococci from Hospitalized Patients and Poultry Products in The Netherlands , 1998, Journal of Clinical Microbiology.

[51]  A. Ambergen,et al.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.

[52]  D. Thompson,et al.  Historical Yearly Usage of Vancomycin , 1998, Antimicrobial Agents and Chemotherapy.

[53]  M. Zervos,et al.  Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin , 1998, Antimicrobial Agents and Chemotherapy.

[54]  B. Cookson,et al.  Diversity of VanA Glycopeptide Resistance Elements in Enterococci from Humans and Nonhuman Sources , 1998, Antimicrobial Agents and Chemotherapy.

[55]  Ronald N. Jones,et al.  Molecular Analysis of Tn1546 inEnterococcus faecium Isolated from Animals and Humans , 1998, Journal of Clinical Microbiology.

[56]  Nicole,et al.  Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands , 1997, Journal of clinical microbiology.

[57]  B. Cookson,et al.  Enterococci as emerging pathogens of humans , 1997, Journal of applied microbiology.

[58]  P. Mertens,et al.  High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame? , 1997, The Journal of antimicrobial chemotherapy.

[59]  G. Tyrrell,et al.  Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain , 1997, Antimicrobial agents and chemotherapy.

[60]  H. Endtz,et al.  Vancomycin-resistant enterococci in vegetarians , 1997, The Lancet.

[61]  G. Wright,et al.  D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Voss,et al.  VRE and meat , 1997, The Lancet.

[63]  R. Weinstein,et al.  Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  R. Weinstein,et al.  Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci , 1996, The Lancet.

[65]  S. Ricke,et al.  Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States , 1996, Antimicrobial agents and chemotherapy.

[66]  H. Endtz,et al.  Vancomycin-resistant enterococci in cats and dogs , 1996, The Lancet.

[67]  P. Courvalin,et al.  Glycopeptide resistance in enterococci. , 1996, Trends in microbiology.

[68]  R A Weinstein,et al.  A Comparison of the Effect of Universal Use of Gloves and Gowns with That of Glove Use Alone on Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit , 1996, Annals of Internal Medicine.

[69]  L. Peterson,et al.  Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates , 1996, Journal of clinical microbiology.

[70]  R. Leclercq,et al.  Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. , 1996, The Journal of infectious diseases.

[71]  S. Handwerger,et al.  Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium , 1995, Antimicrobial agents and chemotherapy.

[72]  F. Moreno,et al.  Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  J. Morris,et al.  Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center , 1995, Annals of Internal Medicine.

[74]  R. Wenzel,et al.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  M. Gilchrist.  Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.

[76]  S. Handwerger,et al.  Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States , 1995, Antimicrobial agents and chemotherapy.

[77]  J. Bates,et al.  Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. , 1994, The Journal of antimicrobial chemotherapy.

[78]  J. Boyce,et al.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.

[79]  S. Abman,et al.  Methaemoglobin during nitric oxide therapy with high-frequency ventilation , 1993, The Lancet.

[80]  T. Frieden,et al.  Emergence of vancomycin-resistant enterococci in New York City , 1993, The Lancet.

[81]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  G. Trenholme,et al.  In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. , 1993, The Journal of infectious diseases.

[83]  R. Wenzel,et al.  The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. , 1993, JAMA.

[84]  M. Arthur,et al.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 , 1993, Journal of bacteriology.

[85]  Mitchell L. Cohen.  Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.

[86]  G. Woods,et al.  Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers , 1992, Annals of Internal Medicine.

[87]  W. Noble,et al.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.

[88]  R. Moellering.  Emergence of Enterococcus as a significant pathogen. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  G. Eliopoulos,et al.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution , 1991, Antimicrobial Agents and Chemotherapy.

[90]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[91]  N. Woodford,et al.  VANCOMYCIN-RESISTANT ENTEROCOCCI , 1988, The Lancet.

[92]  W. Witte,et al.  Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. , 2000, Microbial drug resistance.

[93]  A. Sundsfjord,et al.  Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. , 2000, Microbial drug resistance.

[94]  R. Weinstein,et al.  The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. , 1999, The Journal of infectious diseases.

[95]  H. Claus,et al.  Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. , 1999, Microbial drug resistance.

[96]  A. Tomasz,et al.  Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital. , 1999, Microbial drug resistance.

[97]  A. Sundsfjord,et al.  Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. , 1997, Scandinavian journal of infectious diseases.

[98]  P. Varaldo,et al.  Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. , 1996, Microbial drug resistance.